614. Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections and Bacteremia in Infectious Disease Outpatient Infusion Clinics

BACKGROUND: Long-acting lipoglycopeptides (LGPs) are approved for the treatment of acute bacterial skin and skin-structure infections. Broad Gram-positive coverage and weekly dosing regimens are useful for other diagnoses, but real-world data supporting such use are sparse. We review our experience...

Descripción completa

Detalles Bibliográficos
Autores principales: Metzger, Brian S, Prokesch, Richard C, Bernett, Jorge R, Mandel, Richard M, Nathan, Ramesh V, Stock, Kent, Hardin, Thomas C, Schroeder, Claudia P, Van Anglen, Lucinda J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776532/
http://dx.doi.org/10.1093/ofid/ofaa439.808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776532/
http://dx.doi.org/10.1093/ofid/ofaa439.808

Ejemplares similares